These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 6156337)

  • 1. Effect of oral aspirin dose on platelet aggregation and vascular prostacyclin (PGI2) synthesis in humans and rabbits.
    Ellis EF; Wright KF; Jones PS; Richardson DW; Ellis CK
    J Cardiovasc Pharmacol; 1980; 2(4):387-97. PubMed ID: 6156337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dipyridamole and aspirin in relation to platelet aggregation and vessel wall prostaglandin generation.
    Mehta J; Mehta P
    J Cardiovasc Pharmacol; 1982; 4(4):688-93. PubMed ID: 6181345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of rabbit platelet and aortic cyclooxygenase to inhibition by aspirin.
    McDonald JW; de Kergommeaux BD; Ali M; Hayward CP
    Prostaglandins Leukot Med; 1983 Nov; 12(3):235-44. PubMed ID: 6419233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral aspirin dose on platelet aggregation and arterial prostacyclin synthesis: studies in humans and rabbits.
    Ellis EF; Jones PS; Wright KF; Richardson DW; Ellis CK
    Adv Prostaglandin Thromboxane Res; 1980; 6():313-5. PubMed ID: 6770601
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of arterial PGI2 generation and platelet aggregation by aspirin in rabbits ex vivo.
    Basista M
    Pol J Pharmacol Pharm; 1982; 34(5-6):317-21. PubMed ID: 6821216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prostacyclin in vascular tissue.
    Moncada S; Vane JR
    Fed Proc; 1979 Jan; 38(1):66-71. PubMed ID: 215463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of prostacyclin production and platelet aggregation by aspirin.
    Masotti G; Galanti G; Poggesi L; Abbate R; Neri Serneri GG
    Lancet; 1979 Dec; 2(8154):1213-7. PubMed ID: 92623
    [No Abstract]   [Full Text] [Related]  

  • 8. Platelet interaction with vascular smooth muscle in synthesis of prostacyclin.
    Hechtman DH; Kroll MH; Gimbrone MA; Schafer AI
    Am J Physiol; 1991 May; 260(5 Pt 2):H1544-51. PubMed ID: 1903602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet adhesion and mural platelet thrombus formation on aortic subendothelium of rats, rabbits, and guinea pigs correlate negatively with the vascular PGI2 production.
    Tschopp TB; Baumgartner HR
    J Lab Clin Med; 1981 Sep; 98(3):402-11. PubMed ID: 7021720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients.
    Weksler BB; Pett SB; Alonso D; Richter RC; Stelzer P; Subramanian V; Tack-Goldman K; Gay WA
    N Engl J Med; 1983 Apr; 308(14):800-5. PubMed ID: 6339916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways.
    Krishnamurthi S; Westwick J; Kakkar VV
    Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose aspirin (ASA) renders human platelets more vulnerable to inhibition of aggregation by prostacyclin (PGI2).
    Philp RB; Paul ML
    Prostaglandins Leukot Med; 1983 Jun; 11(2):131-42. PubMed ID: 6348804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandins and platelet aggregation.
    Smith JB
    Acta Med Scand Suppl; 1981; 651():91-9. PubMed ID: 7034481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and platelets: the antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis.
    Schrör K
    Semin Thromb Hemost; 1997; 23(4):349-56. PubMed ID: 9263351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
    Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose aspirin inhibits platelet and venous cyclo-oxygenase in man.
    Preston FE; Greaves M; Jackson CA; Stoddard CJ
    Thromb Res; 1982 Aug; 27(4):477-84. PubMed ID: 6815823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of sulphinpyrazone and aspirin on prostaglandin I2 (prostacyclin) synthesis by endothelial cells.
    Gordon JL; Pearson JD
    Br J Pharmacol; 1978 Dec; 64(4):481-3. PubMed ID: 365283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.